Effects of anti-glaucoma medications on gangion cell survival: the DBA/2J mouse model

被引：85

作者：

Schuettauf, F

Quinto, K

Naskar, R

Zurakowski, D

机构：

[1] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA

[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Childrens Hosp, Dept Biostat, Boston, MA 02115 USA

来源：

VISION RESEARCH | 2002年 / 42卷 / 20期

关键词：

ocular hypertension; model; DBA/2J mouse; retinal ganglion cell survival;

D O I：

10.1016/S0042-6989(02)00188-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

We studied whether several agents, approved or undergoing trials in human glaucoma, were effective in presenting ganglion cell loss in the DBA/2J mouse. Adult DBA/2J mice were treated with timolol, pilocarpine, brimonidine, dorzolamide, or NMDA-receptor antagonist memantine. Surviving retinal ganglion cells of treated and control mice were retrogradely labeled with fluorogold and counted after whole mount preparation. In treated mice, only memantine and timolol had significant effects on retinal ganglion cell survival (P < 0.0001 analysis of variance). Brimonidine was lethal to these mice, and these retinae were not analyzed Further. The DBA/2J mouse represents a promising candidate for further experimentation in ocular hypertension. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：2333 / 2337

页数：5

共 26 条

[1] DBA/2J mouse model for experimental glaucoma: pitfalls and problems
Turner, Anita J.
Vander Wall, Roshana
Gupta, Vivek
Klistorner, Alex
Graham, Stuart L.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (09) : 911 - 922
[2] Effects of Dorzolamide on Retinal and Choroidal Blood Flow in the DBA/2J Mouse Model of Glaucoma
Chandra, Saurav
Muir, Eric R.
Deo, Kaiwalya
Kiel, Jeffrey W.
Duong, Timothy Q.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (03) : 826 - 831
[3] Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma
Wilson, Gina N.
Inman, Denise M.
Denger-Crish, Christine M.
Smith, Matthew A.
Crish, Samuel D.
JOURNAL OF NEUROINFLAMMATION, 2015, 12
[4] Retinal neurodegeneration in the DBA/2J mouse—a model for ocular hypertension
Frank Schuettauf
Robert Rejdak
Michal Walski
Malgorzata Frontczak-Baniewicz
Michael Voelker
Georgios Blatsios
Kei Shinoda
Zbigniew Zagorski
Eberhart Zrenner
Pawel Grieb
Acta Neuropathologica, 2004, 107 : 352 - 358
[5] Retinal neurodegeneration in the DBA/2J mouse - a model for ocular hypertension
Schuettauf, F
Rejdak, R
Walski, M
Frontczak-Baniewicz, M
Voelker, M
Blatsios, G
Shinoda, K
Zagorski, Z
Zrenner, E
Grieb, P
ACTA NEUROPATHOLOGICA, 2004, 107 (04) : 352 - 358
[6] Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Cooper, Melissa L.
Crish, Samuel D.
Inman, Denise M.
Horner, Philip J.
Calkins, David J.
EXPERIMENTAL EYE RESEARCH, 2016, 150 : 22 - 33
[7] The Activity of Lowering Intraocular Pressure of Cassiae Seed Extract in a DBA/2J Mouse Glaucoma Model
Horng, Chi-Ting
Tsai, Ming-Liang
Chien, Shang-Tao
Kao, Wei-Tsung
Tsai, Ming-Kai
Chang, Tsung-Hsung
Chen, Fu-An
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (01) : 48 - 54
[8] Effects of chronic mild hyperoxia on retinal and choroidal blood flow and retinal function in the DBA/2J mouse model of glaucoma
Muir, Eric R.
Chandra, Saurav B.
Narayanan, Divya
Zhang, Vincent
Zhang, Ike
Jiang, Zhao
Kiel, Jeffrey W.
Duong, Timothy Q.
PLOS ONE, 2022, 17 (03):
[9] Electrophysiological deficits in the retina of the DBA/2J mouse
Harazny, Joanna
Scholz, Michael
Buder, Thomas
Lausen, Berthold
Kremers, Jan
DOCUMENTA OPHTHALMOLOGICA, 2009, 119 (03) : 181 - 197
[10] Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma
Dengler-Crish, Christine M.
Smith, Matthew A.
Inman, Denise M.
Wilson, Gina N.
Young, Jesse W.
Crish, Samuel D.
FRONTIERS IN NEUROSCIENCE, 2014, 8

← 1 2 3 →